In an expert Q&A, Hospital for Special Surgery’s Lisa Mandl, MD, MPH, discusses the role of genicular nerve ablation in ...

Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering first-in-class therapeutics based on small-molecule inhibition of CLK/DYRK kinases, announced today that ...

If the approach translates to humans, it could mark a significant shift in how degenerative joint diseases or osteoarthritis, are treated.

Studies show exercise, braces, and water therapy can reduce pain and improve mobility for millions with knee arthritis.

Stanford researchers develop a therapy that regenerates cartilage and blocks osteoarthritis in ageing joints, showing promise for future treatments that restore joint health Stanford researchers have ...

Researchers in China have found no statistically significant advantage for infrapatellar fat pad glucocorticoid injection ...

Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a first-in-class treatment for osteoarthritis (OA), today announces the US Food and Drug Administration (FDA) has accepted ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

Stem cell treatment targeting the bone beneath the knee reduced pain and improved movement more effectively than joint injections in osteoarthritis patients.

In a revolutionary discovery, scientists have identified a specific protein that, when blocked, allows the body to naturally ...

The EVA for DHTs used by people with hip and knee osteoarthritis (PDF) recommends eight products, namely: GetUBetter; Good ...

A study in mice by researchers from Stanford University has traced the loss of cartilage that comes with aging to a single ...